ARROWHEAD PHARMACEUTICALS, INC.
ARWRUS売上高
$829M
百万USD
営業利益
$98M
百万USD
純利益
$-2M
百万USD
ROE
-0.3%
最新FY
EPS
$-0.01
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $21M | $-21M | $-0.20 |
| FY2021 | Q2 | $33M | $-27M | $-0.26 |
| FY2021 | Q3 | $46M | $-30M | $-0.29 |
| FY2021 | FY | $138M | $-141M | $-1.36 |
| FY2022 | Q1 | $27M | $-63M | $-0.60 |
| FY2022 | Q2 | $152M | $44M | $0.41 |
| FY2022 | Q3 | $32M | $-72M | $-0.68 |
| FY2022 | FY | $243M | $-176M | $-1.67 |
| FY2023 | Q1 | $63M | $-41M | $-0.39 |
| FY2023 | Q2 | $146M | $49M | $0.45 |
| FY2023 | Q3 | $16M | $-103M | $-0.96 |
| FY2023 | FY | $241M | $-205M | $-1.92 |
| FY2024 | Q1 | $4M | $-133M | $-1.24 |
| FY2024 | Q2 | $0M | $-125M | $-1.02 |
| FY2024 | Q3 | $0M | $-171M | $-1.38 |
| FY2024 | FY | $4M | $-599M | $-5.00 |
| FY2025 | Q1 | $3M | $-173M | $-1.39 |
| FY2025 | Q2 | $543M | $370M | $2.75 |
| FY2025 | Q3 | $28M | $-175M | $-1.26 |
| FY2025 | FY | $829M | $-2M | $-0.01 |
| FY2026 | Q1 | $264M | $31M | $0.22 |
| FY2026 | Q2 | $74M | $-133M | $-0.93 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | $169M | $88M | $138M | $243M | $241M | $4M | $829M |
| 営業利益 | $-82M | $-37M | $-56M | $61M | $-93M | $-149M | $-179M | $-205M | $-601M | $98M |
| 純利益 | $-82M | - | - | $68M | $-85M | $-141M | $-176M | $-205M | $-599M | $-2M |
| 総資産 | $128M | $104M | $112M | $350M | $523M | $710M | $692M | $766M | $1.1B | $1.4B |
| 純資産 | $95M | $81M | $95M | $244M | $462M | $409M | $418M | $287M | $191M | $503M |
| 自己資本 | $96M | $81M | $96M | $245M | $462M | - | $399M | $271M | $185M | $466M |
| 営業CF | - | - | $-47M | $173M | $-95M | $171M | $-136M | $-154M | $-463M | $180M |
| EPS | - | - | - | $0.69 | $-0.84 | $-1.36 | $-1.67 | $-1.92 | $-5.00 | $-0.01 |
| BPS | $1.29 | $1.09 | $1.04 | $2.56 | $4.49 | - | $3.76 | $2.53 | $1.49 | $3.43 |
| ROE | -85.5% | - | - | 27.8% | -18.3% | - | -44.2% | -75.7% | -323.3% | -0.3% |